Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis.

Sven H LoosenMax Schulze-HagenMihael VucurJoao GorgulhoPia PaffenholzFabian BenzRaphael MohrMünevver DemirAlexander WreeChristiane KuhlChristian TrautweinFrank TackePhilipp BrunersTom LueddeChristoph Roderburg

Published in: JGH open : an open access journal of gastroenterology and hepatology (2021)

Baseline suPAR serum levels provide important information on the postinterventional outcome of liver cancer patients receiving TACE.

Keyphrases

radiofrequency ablation
healthcare
health information
free survival
social media